Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2020Clinical and Translational GastroenterologyOpen Access

Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR Study

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRocío Múñoz‐HernándezUniversidad de ValladolidJAJavier AmpueroCentro de Investigación Biomédica en RedRMRaquel MillánInstituto de Salud Carlos III

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Múñoz‐Hernández et al. (2020) studied this question.

synapsesocial.com/papers/6a75856b72c9f0ed5b5ffaf9https://doi.org/10.14309/ctg.0000000000000203
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)1993 · 27,987 citations
  2. 2Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.1997 · 488 citations
  3. 3Improvement of liver stiffness in patients with hepatitis C virus infection who received direct‐acting antiviral therapy and achieved sustained virological response2017 · 108 citations
  4. 4Which parameter is better to define endothelial dysfunction in a test of postocclusive hyperemia measured by Laser-Doppler flowmetry?2011 · 29 citations